Search research articles
Contact Us
Filters
Showing results (121-130 of 169) with videos related to
Page
of 17
Sort By:
Journal of the National Cancer Institute
|
October 1, 1971
Antibodies to various herpesviruses in sera from patients with sarcoidosis
B Wahren, E Carlens, A Espmark, et al.
International Journal of Cancer
|
March 15, 1972
EB-virus associated serology in malignant disease: antibody levels to viral capsid antigens (VCA), membrane antigens (MA) and early antigens(EA) in patients with various neoplastic conditions
A De Schryver, G Klein, G Henle, et al.
Nature
|
December 12, 1970
EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx
H zur Hausen, H Schulte-Holthausen, G Klein, et al.
International Journal of Cancer
|
March 15, 1974
Epstein-Barr virus: transformation of non-human primate lymphocytes in vitro
L Falk, L Wolfe, F Deinhardt, et al.
IARC Scientific Publications
|
January 1, 1975
Epstein-Barr virus (EBV)-associated antibody patterns in relation to the deficiency of cell-mediated immunity in patients with Hodgkin's disease
B Johansson, D Killander, G Holm, et al.
Journal of the National Cancer Institute
|
April 1, 1971
Antibodies to early Epstein-Barr virus-induced antigens in Burkitt's lymphoma
G Henle, W Henle, G Klein, et al.
Cellular Immunology
|
January 1, 1984
EGNA-specific LIF production of human lymphocyte subsets
R Szigeti, G Masucci, B Ehlin-Henriksson, et al.
European Journal of Cancer & Clinical Oncology
|
April 1, 1987
Analysis of Epstein-Barr virus-specific and non-specific immune functions in a patient during the development of a non-Hodgkin's lymphoma
G Masucci, H Mellstedt, M G Masucci, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 1, 1986
Four virally determined nuclear antigens are expressed in Epstein-Barr virus-transformed cells
B Kallin, J Dillner, I Ernberg, et al.
International Journal of Cancer
|
June 15, 1989
Relationship between clinical stage, histopathology and antibody titers against the second Epstein-Barr virus nuclear antigen (EBNA-2) in non-Hodgkin's lymphoma patients
G Masucci, H Mellstedt, G Henle, et al.
Page
of 17
Search research articles
Search
Showing results (121-130 of 169) with videos related to
Sort By:
Page
of 17
Journal of the National Cancer Institute
|
October 1, 1971
Antibodies to various herpesviruses in sera from patients with sarcoidosis
B Wahren, E Carlens, A Espmark, et al.
International Journal of Cancer
|
March 15, 1972
EB-virus associated serology in malignant disease: antibody levels to viral capsid antigens (VCA), membrane antigens (MA) and early antigens(EA) in patients with various neoplastic conditions
A De Schryver, G Klein, G Henle, et al.
Nature
|
December 12, 1970
EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx
H zur Hausen, H Schulte-Holthausen, G Klein, et al.
International Journal of Cancer
|
March 15, 1974
Epstein-Barr virus: transformation of non-human primate lymphocytes in vitro
L Falk, L Wolfe, F Deinhardt, et al.
IARC Scientific Publications
|
January 1, 1975
Epstein-Barr virus (EBV)-associated antibody patterns in relation to the deficiency of cell-mediated immunity in patients with Hodgkin's disease
B Johansson, D Killander, G Holm, et al.
Journal of the National Cancer Institute
|
April 1, 1971
Antibodies to early Epstein-Barr virus-induced antigens in Burkitt's lymphoma
G Henle, W Henle, G Klein, et al.
Cellular Immunology
|
January 1, 1984
EGNA-specific LIF production of human lymphocyte subsets
R Szigeti, G Masucci, B Ehlin-Henriksson, et al.
European Journal of Cancer & Clinical Oncology
|
April 1, 1987
Analysis of Epstein-Barr virus-specific and non-specific immune functions in a patient during the development of a non-Hodgkin's lymphoma
G Masucci, H Mellstedt, M G Masucci, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 1, 1986
Four virally determined nuclear antigens are expressed in Epstein-Barr virus-transformed cells
B Kallin, J Dillner, I Ernberg, et al.
International Journal of Cancer
|
June 15, 1989
Relationship between clinical stage, histopathology and antibody titers against the second Epstein-Barr virus nuclear antigen (EBNA-2) in non-Hodgkin's lymphoma patients
G Masucci, H Mellstedt, G Henle, et al.
Page
of 17